Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 055512/0267 | |
| Pages: | 6 |
| | Recorded: | 03/05/2021 | | |
| Attorney Dkt #: | 071875-000096 (CENTRICS) |
| Conveyance: | CORRECTIVE ASSIGNMENT TO CORRECT THE CORRECTION TO ASSIGNEE NAME TO READ AS CENTRICSBIO, INC. PREVIOUSLY RECORDED AT REEL: 054495 FRAME: 0442. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT OF ASSIGNORS INTEEREST. |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17059995
|
Filing Dt:
|
11/30/2020
|
|
Publication #:
|
|
Pub Dt:
|
08/05/2021
| | | | |
|
Title:
|
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER, CONTAINING CD300C EXPRESSION INHIBITOR OR ACTIVITY INHIBITOR
|
|
|
Assignee
|
|
|
|
|
| 3F, BK TOWER, 28, BEOBWON-RO 11-GIL, SONGPA-GU |
| SEOUL, KOREA, REPUBLIC OF 05836 |
|
|
Correspondence name and address
|
| |
VORYS, SATER, SEYMOUR & PEASE LLP
|
| |
1909 K ST., NW
|
| |
9TH FLOOR
|
| |
WASHINGTON, DC 20006-1152
|
Search Results as of:
09/22/2024 09:37 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
